IBDEI0IJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8995,0)
 ;;=174.4^^55^602^12
 ;;^UTILITY(U,$J,358.3,8995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8995,1,4,0)
 ;;=4^Cancer, Upper Outer Breast
 ;;^UTILITY(U,$J,358.3,8995,1,5,0)
 ;;=5^174.4
 ;;^UTILITY(U,$J,358.3,8995,2)
 ;;=Cancer, Upper Outer Breast^267198
 ;;^UTILITY(U,$J,358.3,8996,0)
 ;;=610.0^^55^602^13
 ;;^UTILITY(U,$J,358.3,8996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8996,1,4,0)
 ;;=4^Cyst,Breast
 ;;^UTILITY(U,$J,358.3,8996,1,5,0)
 ;;=5^610.0
 ;;^UTILITY(U,$J,358.3,8996,2)
 ;;=^112247
 ;;^UTILITY(U,$J,358.3,8997,0)
 ;;=625.3^^55^602^14
 ;;^UTILITY(U,$J,358.3,8997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8997,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,8997,1,5,0)
 ;;=5^625.3
 ;;^UTILITY(U,$J,358.3,8997,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,8998,0)
 ;;=610.1^^55^602^18
 ;;^UTILITY(U,$J,358.3,8998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8998,1,4,0)
 ;;=4^Fibrocystic Disease,Breast
 ;;^UTILITY(U,$J,358.3,8998,1,5,0)
 ;;=5^610.1
 ;;^UTILITY(U,$J,358.3,8998,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,8999,0)
 ;;=217.^^55^602^2
 ;;^UTILITY(U,$J,358.3,8999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8999,1,4,0)
 ;;=4^Benign Neoplasm Breast
 ;;^UTILITY(U,$J,358.3,8999,1,5,0)
 ;;=5^217.
 ;;^UTILITY(U,$J,358.3,8999,2)
 ;;=^267638
 ;;^UTILITY(U,$J,358.3,9000,0)
 ;;=617.9^^55^602^15
 ;;^UTILITY(U,$J,358.3,9000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9000,1,4,0)
 ;;=4^Endometriosis
 ;;^UTILITY(U,$J,358.3,9000,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,9000,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,9001,0)
 ;;=618.6^^55^602^16
 ;;^UTILITY(U,$J,358.3,9001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9001,1,4,0)
 ;;=4^Enterocele,Vaginal
 ;;^UTILITY(U,$J,358.3,9001,1,5,0)
 ;;=5^618.6
 ;;^UTILITY(U,$J,358.3,9001,2)
 ;;=^56796
 ;;^UTILITY(U,$J,358.3,9002,0)
 ;;=625.6^^55^602^20
 ;;^UTILITY(U,$J,358.3,9002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9002,1,4,0)
 ;;=4^Incontin,Female Stress
 ;;^UTILITY(U,$J,358.3,9002,1,5,0)
 ;;=5^625.6
 ;;^UTILITY(U,$J,358.3,9002,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,9003,0)
 ;;=611.72^^55^602^21
 ;;^UTILITY(U,$J,358.3,9003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9003,1,4,0)
 ;;=4^Lump/Mass In Breast
 ;;^UTILITY(U,$J,358.3,9003,1,5,0)
 ;;=5^611.72
 ;;^UTILITY(U,$J,358.3,9003,2)
 ;;=Lump/Mass in Breast^72018
 ;;^UTILITY(U,$J,358.3,9004,0)
 ;;=795.00^^55^602^1
 ;;^UTILITY(U,$J,358.3,9004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9004,1,4,0)
 ;;=4^Abnormal Pap Smear, Nos
 ;;^UTILITY(U,$J,358.3,9004,1,5,0)
 ;;=5^795.00
 ;;^UTILITY(U,$J,358.3,9004,2)
 ;;=Abnormal Pap Smear, NOS^117041
 ;;^UTILITY(U,$J,358.3,9005,0)
 ;;=618.00^^55^602^29
 ;;^UTILITY(U,$J,358.3,9005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9005,1,4,0)
 ;;=4^Vaginal Wall Prolpse Nos
 ;;^UTILITY(U,$J,358.3,9005,1,5,0)
 ;;=5^618.00
 ;;^UTILITY(U,$J,358.3,9005,2)
 ;;=^331533
 ;;^UTILITY(U,$J,358.3,9006,0)
 ;;=611.89^^55^602^19
 ;;^UTILITY(U,$J,358.3,9006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9006,1,4,0)
 ;;=4^Hematoma,Breast
 ;;^UTILITY(U,$J,358.3,9006,1,5,0)
 ;;=5^611.89
 ;;^UTILITY(U,$J,358.3,9006,2)
 ;;=^336616
 ;;^UTILITY(U,$J,358.3,9007,0)
 ;;=173.51^^55^602^10
 ;;^UTILITY(U,$J,358.3,9007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9007,1,4,0)
 ;;=4^Cancer, Skin Of Breast
 ;;^UTILITY(U,$J,358.3,9007,1,5,0)
 ;;=5^173.51
 ;;^UTILITY(U,$J,358.3,9007,2)
 ;;=^340479
 ;;^UTILITY(U,$J,358.3,9008,0)
 ;;=175.9^^55^603^1
 ;;^UTILITY(U,$J,358.3,9008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9008,1,4,0)
 ;;=4^Ca, Male Breast
 ;;^UTILITY(U,$J,358.3,9008,1,5,0)
 ;;=5^175.9
